GFAP and NfL exhibited different patterns of elevation in AD and FTD patients, as has also been reported in previous studies [12,18,19,33], but their discrimination values only reached 0.70 and 0.78, respectively. The gene discussed is NEFL; the disease is Alzheimer disease.